Sermorelin / GHRP-6 / GHRP-2 Blend is a research peptide formulation combining three well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Sermorelin, Growth Hormone–Releasing Peptide-6 (GHRP-6), and Growth Hormone–Releasing Peptide-2 (GHRP-2). Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH), while GHRP-6 and GHRP-2 are growth hormone secretagogue receptor (GHS-R) agonists with differing receptor activity profiles. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release, receptor signaling pathways, and coordinated endocrine response mechanisms.
Prior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Sermorelin has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a relatively short duration of activity. GHRP-6 has been widely researched for its role in ghrelin receptor activation and its influence on growth hormone secretion amplitude and frequency, while GHRP-2 has been examined for its potent receptor binding and effects on growth hormone release dynamics. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion amplitude, and endocrine signaling coordination.
Currently, the Sermorelin / GHRP-6 / GHRP-2 Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, appetite-related hormone interactions, and circadian growth hormone release patterns. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
The Sermorelin, GHRP-6, GHRP-2 (3mg / 3mg / 3mg) Blend is formulated for laboratory research focused on growth hormone axis signaling, endocrine regulation, and hypothalamic–pituitary communication pathways. This triple-peptide blend combines a growth hormone–releasing hormone analog with two growth hormone secretagogues, allowing researchers to study how multiple endocrine signaling mechanisms influence pulsatile growth hormone release.
Multi-pathway research models are commonly used in peptide science to evaluate how complementary hormone signaling pathways interact in controlled experimental environments. By combining peptides that stimulate the GH axis through distinct mechanisms, researchers may observe hormone pulse dynamics, receptor activation responses, and downstream endocrine biomarker behavior.
Sermorelin, GHRP-6, GHRP-2 (3mg / 3mg / 3mg) – Research Specifications:
| Format | Lyophilized peptide blend (research format) |
| Contents | Sermorelin (3mg) + GHRP-6 (3mg) + GHRP-2 (3mg) |
| Purity / Identity | Research-grade; refer to Certificate of Analysis (COA) for lot-specific analytical documentation |
| Source | Peptide synthesis using controlled manufacturing and QC procedures |
| Appearance | Lyophilized powder |
| Storage Conditions | Store sealed in a cool, dry environment away from heat, light, and moisture |
| Research Use Only | Supplied exclusively for laboratory research. Not for human or veterinary use. |
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) frequently studied in endocrine research examining hypothalamic signaling and pituitary hormone regulation. In controlled experimental models, researchers may analyze how Sermorelin stimulates upstream GH-axis pathways and influences hormone pulse timing.
GHRP-6 and GHRP-2 are growth hormone secretagogues studied for their interaction with ghrelin receptors, which play a role in hormone signaling associated with pituitary growth hormone release. These compounds are often examined in laboratory research investigating receptor-mediated endocrine responses and growth hormone secretion dynamics.
When combined in a multi-peptide research model, Sermorelin, GHRP-6, and GHRP-2 allow investigators to examine how hypothalamic stimulation interacts with ghrelin receptor activation. These studies frequently analyze hormone pulse frequency, secretion amplitude, and downstream biomarker fluctuations associated with GH-axis signaling.
Researchers studying the individual peptides used in this blend may reference the product pages for Sermorelin, GHRP-6, and GHRP-2.
Important Research Notice: Nordsci products are supported by lot-specific analytical documentation. Certificates of Analysis are available for laboratory verification, research compliance documentation, and reproducibility support.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
A primary research application of this peptide blend involves studying pulsatile growth hormone release. Researchers may evaluate endocrine marker changes over timed sampling intervals to observe how combined signaling pathways influence hormone pulse patterns.
Because Sermorelin stimulates upstream GHRH pathways while GHRP-6 and GHRP-2 activate ghrelin receptor signaling, this blend provides a useful experimental framework for studying multi-pathway endocrine signaling interactions.
Growth hormone research frequently includes measurement of downstream endocrine biomarkers. Investigators may evaluate hormone-related markers that fluctuate following activation of GH-axis pathways within controlled research models.
Some research protocols compare multi-peptide blends to single-compound experiments. This approach allows investigators to determine whether hormone signaling responses are driven by individual compounds or by combined receptor-pathway interactions.
The Sermorelin, GHRP-6, GHRP-2 Blend should be handled using standard peptide laboratory procedures. Researchers should maintain contamination-free environments, follow appropriate storage protocols, and document all experimental variables to support reproducibility.
Protocol Design Considerations: Growth hormone signaling research is influenced by circadian rhythm patterns, metabolic baseline conditions, environmental stressors, and experimental timing. Carefully structured protocols and controlled laboratory environments are essential for accurate interpretation of endocrine data.
Note: The information provided here is intended strictly for research reference. All experimental work should be conducted by qualified professionals in appropriate laboratory environments.
Each batch of this peptide blend includes a Certificate of Analysis verifying peptide identity and quality parameters. These analytical reports assist research laboratories with procurement validation, regulatory documentation, and experiment reproducibility tracking.
Research laboratories sourcing peptides typically prioritize consistent synthesis standards, analytical documentation, and reliable manufacturing processes. Nordsci Peptides provides research-grade peptide materials supported by quality assurance procedures and analytical reporting designed to support reproducible research outcomes.
IMPORTANT: This product is supplied exclusively for laboratory research use. It is not approved for human consumption or clinical use. Researchers are responsible for ensuring compliance with all applicable institutional and regulatory guidelines.
